Context Therapeutics Inc. (CNTX) vs Kyntra Bio Inc (KYNB)
- Context Therapeutics Inc. CNTX 0.24 0.00%
- Kyntra Bio Inc KYNB 4.85 −9.51%
Context Therapeutics Inc. and Kyntra Bio Inc are both Biotechnology companies. Context Therapeutics Inc. and Kyntra Bio Inc are of similar size ($22.1M and $21.7M). Context Therapeutics Inc. has negative trailing earnings, so its P/E is not meaningful; Kyntra Bio Inc trades at 0.1×. Kyntra Bio Inc has the higher net margin (3,967.8% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Context Therapeutics Inc. leads on 6 and Kyntra Bio Inc on 5.
Valuation
Profitability
| Metric | CNTX | KYNB | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 6.28% | 65.16% |
| Operating margin | 0.00% | (1,089.78%) | 0.00% |
| Net margin | 0.00% | 3,967.77% | 0.00% |
| Free cash flow margin | 0.00% | (824.19%) | 0.00% |
| Return on equity | (76.14%) | (157.83%) | (56.36%) |
| Return on assets | (68.96%) | 131.26% | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack